Показано 0 из 0
Дата |
---|
20:52 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.88
|
3.96
|
3.92
|
3.92
|
3.92
|
3.92
|
|
|
|
|
3.94
|
4.02
|
3.88
|
3.88
|
3.88
|
3.88
|
|
|
|
|
3.88
|
3.96
|
3.56
|
3.56
|
3.56
|
3.56
|
|
|
|
|
3.58
|
3.64
|
3.50
|
3.50
|
3.50
|
3.50
|
|
|
|
|
3.54
|
3.60
|
3.58
|
3.58
|
3.58
|
3.58
|
|
|
|
|
3.66
|
3.72
|
3.42
|
3.42
|
3.42
|
3.42
|
|
|
|
|
3.16
|
3.20
|
3.24
|
3.24
|
3.24
|
3.24
|
|
|
|
|
3.24
|
3.30
|
3.14
|
3.14
|
3.14
|
3.14
|
|
|
|
|
3.20
|
3.24
|
3.14
|
3.14
|
3.14
|
3.14
|
|
|
|
|
3.16
|
3.22
|
3.18
|
3.18
|
3.18
|
3.18
|
|
|
|
|
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF.